Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.
Endocr Pract. 2009 Jul-Aug;15(5):438-49. doi: 10.4158/EP09101.ORR.
Yamshchikov AV1, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V.
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30030, USA. AYAMSHC at emory.edu
- Influenza prevented by 40 ng levels or treated with vitamin D hammer (50,000 IU) – June 2015
- How to significantly reduce your risk of contracting the Zika virus
- All items in category Virus
Immunity category starts with
189 items in Immunity category
see alsoVirus category listing has
380 items along with related searches
Overview Influenza and vitamin D
Search for treg OR "t-cell" in Vitamin D Life 1440 items as of Jan 2020
Search VitaminDWik for INFECTION in title 50 items as of Aug 2019
Search VitaminDWik for BACTERIA in title 25 items as of Aug 2019
Vitamin D and the Immune System – chapter Aug 2019
7X less risk of influenza if Vitamin D levels higher than 30 ng – Oct 2017
Common cold prevented and treated by Vitamin D, Vitamin C, Zinc, and Echinacea – review April 2018
Vitamin D improves T Cell immunity – RCT Feb 2016
Vitamin D Every Day to Keep the Infection Away 2015 file
shows increasing publications on vitamin D and Infection
[https://scholar.google.com/scholar?cites=9829933637340480930&as_sdt=5,48&sciodt=0,48&hl=en|335 studies reference this study as of Oct 2020
OBJECTIVE: To review the existing human controlled intervention studies of vitamin D as adjunctive therapy in settings of infection and provide recommendations for design and implementation of future studies in this field on the basis of the evidence reviewed.
METHODS: We conducted a systematic review of randomized controlled clinical trials that studied vitamin D for treatment or prevention of infectious diseases in humans. Studies from 1948 through 2009 were identified through search terms in PubMed and Ovid MEDLINE.
RESULTS: Thirteen published controlled trials were identified by our search criteria. Ten trials were placebo controlled, and 9 of the 10 were conducted in a rigorous double-blind design. The selected clinical trials demonstrated substantial heterogeneity in baseline patient demographics, sample size, and vitamin D intervention strategies. Serious adverse events attributable to vitamin D supplementation were rare across all studies. On the basis of studies reviewed to date, the strongest evidence supports further research into adjunctive vitamin D therapy for
- viral upper respiratory tract illnesses.
In the selected studies, certain aspects of study design are highlighted to help guide future clinical research in the field.
CONCLUSION: More rigorously designed clinical trials are needed for further evaluation of the relationship between vitamin D status and the immune response to infection as well as for delineation of necessary changes in clinical practice and medical care of patients with vitamin D deficiency in infectious disease settings.
Download the PDF from Vitamin D LifeMany Infectious diseases (virus) treated and prevented by Vitamin D – review July 2009
4447 visitors, last modified 15 Oct, 2020,This page is in the following categories (# of items in each category)Immunity 189 Intervention 639 Virus 380